MDXL (MediXall Group) ROE % Adjusted to Book Value: Negative Equity% (As of Sep. 2024)


What is MediXall Group ROE % Adjusted to Book Value?

MediXall Group MDXL ROE % Adjusted to Book Value is Negative Equity% as of Sep. 2024.

MediXall Group's ROE % for the quarter that ended in Sep. 2024 was Negative Equity. MediXall Group's PB Ratio for the quarter that ended in Sep. 2024 was N/A. MediXall Group's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was Negative Equity.

MediXall Group ROE % Adjusted to Book Value Related Terms

MediXall Group ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for MediXall Group's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MediXall Group ROE % Adjusted to Book Value Chart

MediXall Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.82 -6.61 0.00 0.00 0.00

MediXall Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 Negative Equity

MDXL vs ICCT, VEEV, GEHC: ROE % Adjusted to Book Value Comparison

For the Health Information Services subindustry, MediXall Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MediXall Group ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MediXall Group's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where MediXall Group's ROE % Adjusted to Book Value falls into.


MediXall Group ROE % Adjusted to Book Value Calculation

MediXall Group's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

MediXall Group's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=Negative Equity / N/A
=Negative Equity

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of Negative Equity% mean?
MediXall Group (MDXL) has a ROE % Adjusted to Book Value of Negative Equity% as of Sep. 2024. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on MediXall Group and its competitors.
Is MediXall Group's ROE % Adjusted to Book Value too high?
MediXall Group's current ROE % Adjusted to Book Value is Negative Equity%.
How does MediXall Group's ROE % Adjusted to Book Value compare to ICCT and VEEV?
MediXall Group's ROE % Adjusted to Book Value of Negative Equity% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on MediXall Group and its competitors. MediXall Group's current ROE % Adjusted to Book Value is Negative Equity%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MediXall Group stock overvalued right now?
MediXall Group (MDXL) has a current ROE % Adjusted to Book Value of Negative Equity%. The current ROE % Adjusted to Book Value is Negative Equity%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For MediXall Group (MDXL), the current ROE % Adjusted to Book Value is Negative Equity% as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MediXall Group Business Description

Address 104 North 4th Street, Leesburg, FL, USA, 34748
MediXall Group Inc is an innovation-driven technology company designed to deliver health and well-being services which address gaps in access to care, spiraling healthcare costs, and the pain points faced by both consumers and businesses. It has developed a cloud-based electronic marketplace where clients can shop for medical services; diagnostic procedures and services; and medical equipment and devices. The company's platform connects physicians and service providers to patients, and payers to the physicians and service providers, across all healthcare settings. The company generates revenue from employer customers and consumer subscription fees.